Tag: NASDAQ:AMGN

Health

Abbvie Inc (NYSE:ABBV), Samsung Bioepis In Deal; Humira Biosimilar U.S. Release...

Ash Sandifer -
Health

Amgen, Inc (NASDAQ:AMGN) Has Submitted A Supplemental Biologics Licence Application For...

Aaron Lyons -
Amgen Inc
Health

Amgen, Inc. (NASDAQ:AMGN)’s Adalimumab Biosimilar Drug, ABP 501 Gets Nod From...

Brandon Manns -
Business

Amgen, Inc. (NASDAQ:AMGN) Reports Topline Results For Acute Lymphoblastic Leukemia Treatment

Neha Rathod -
Health

Amgen, Inc. (NASDAQ:AMGN) 1Q Disappoints

Neha Rathod -
Health

Research For Human Antibiotic Amgen, Inc.(NASDAQ:AMGN)

Brandon Manns -
Health

Zalicus Inc (NASDAQ:ZLCS): Updates on Clinical Studies – NVS, AMGN

Neha Rathod -
© Copyright 2018 - Financials Trend